Anti-inflammatory add-on treatment after certain aortic conditions
Part of Heart & circulation clinical trials.
This study tests whether an “add-on” anti-inflammatory approach can help after surgery for certain problems affecting the aorta (the body’s main artery) soon after symptoms begin. It may be designed to reduce inflammation-related complications in people who are treated quickly and can join follow-up.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older
- You have a confirmed aortic condition such as aortic dissection, penetrating aortic ulcer, or intramural hematoma
- Your symptoms began within 14 days after surgery
- You received medical therapy or an open, endovascular, or hybrid repair for the aortic condition
- You agree (or your guardian agrees) to join the study and follow the visit schedule
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing a new way to quickly diagnose a tear or blood clot in the aorta (the main artery from the heart) by looking at a special score. If you have sudden chest, back, or belly pain, this trial may help find the cause faster.
This trial tests whether taking a cholesterol-lowering medicine (a statin) after certain aortic surgeries can reduce harmful changes in the heart and other organs. You might benefit by lowering the risk of ongoing damage after your acute aortic condition and surgery.
This study tests whether a simple blood test (D-dimer) combined with a risk score can safely identify patients who do not have a life-threatening tear in the aorta (the main artery from the heart). If it works, it could help doctors avoid unnecessary imaging scans and get patients diagnosed faster.
This study looks at whether thymosin A1 can reduce immune-related problems and organ injury after emergency surgery for an acute aortic condition. If you qualify, you may receive thymosin A1 as part of the treatment plan to see if it improves recovery.
This trial uses artificial intelligence to help choose the best emergency surgery for people with a sudden tear in the main artery of the body (acute aortic dissection). It aims to improve outcomes by matching the treatment to each patient's specific condition.
This study looks at whether a comprehensive add-on treatment—starting with immune medicine and then a heart procedure when needed—can improve outcomes for people whose coronary artery disease is getting worse quickly. It focuses on cases where inflammation is likely driving new artery blockages or worsening chest pain.
Hear when a new Acute Aortic Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.